Simplex Trading, LLC Allakos Inc. Transaction History

Simplex Trading, LLC

  • $3.28 Billion
  • Q4 2024

A detailed history of Simplex Trading, LLC transactions in Allakos Inc. stock. As of the latest transaction made, Simplex Trading, LLC holds 136,848 shares of ALLK stock, worth $39,685. This represents 0.01% of its overall portfolio holdings.

Number of Shares
136,848
Previous 95,673 43.04%
Holding current value
$39,685
Previous $62,000 166.13%
% of portfolio
0.01%
Previous 0.0%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 11, 2025
BUY
$0.62 - $1.5 $25,528 - $61,762
41,175 Added 43.04%
136,848 $165,000
Q3 2024

Nov 08, 2024
BUY
$0.54 - $0.92 $51,392 - $87,558
95,172 Added 18996.41%
95,673 $62,000
Q2 2024

Jul 25, 2024
SELL
$1.0 - $1.45 $15,458 - $22,414
-15,458 Reduced 96.86%
501 $0
Q1 2024

Apr 25, 2024
SELL
$1.02 - $3.23 $8,289 - $26,250
-8,127 Reduced 33.74%
15,959 $20,000
Q4 2023

Feb 02, 2024
BUY
$1.72 - $3.18 $41,427 - $76,593
24,086 New
24,086 $65,000
Q1 2023

Apr 27, 2023
BUY
$4.3 - $8.27 $16,051 - $30,871
3,733 Added 794.26%
4,203 $18,000
Q4 2022

Feb 02, 2023
SELL
$5.66 - $8.42 $466,531 - $694,026
-82,426 Reduced 99.43%
470 $3,000
Q3 2022

Nov 04, 2022
SELL
$3.02 - $6.12 $23,284 - $47,185
-7,710 Reduced 8.51%
82,896 $507,000
Q2 2022

Aug 03, 2022
BUY
$2.6 - $6.14 $231,514 - $546,730
89,044 Added 5700.64%
90,606 $283,000
Q1 2022

May 02, 2022
SELL
$5.08 - $9.81 $72,405 - $139,821
-14,253 Reduced 90.12%
1,562 $8,000
Q4 2021

Feb 23, 2022
BUY
$8.55 - $111.89 $110,808 - $1.45 Million
12,960 Added 453.94%
15,815 $154,000
Q3 2021

Oct 28, 2021
BUY
$76.53 - $110.43 $15,306 - $22,086
200 Added 7.53%
2,855 $249,000
Q2 2021

Aug 12, 2021
SELL
$85.37 - $114.1 $175,862 - $235,046
-2,060 Reduced 43.69%
2,655 $226,000
Q1 2021

Apr 26, 2021
BUY
$109.73 - $153.66 $517,376 - $724,506
4,715 New
4,715 $541,000
Q4 2020

Feb 02, 2021
SELL
$79.58 - $152.45 $21,327 - $40,856
-268 Closed
0 $0
Q3 2020

Oct 14, 2020
SELL
$66.43 - $90.99 $9,300 - $12,738
-140 Reduced 34.31%
268 $21,000
Q2 2020

Jul 13, 2020
SELL
$44.04 - $80.69 $9,336 - $17,106
-212 Reduced 34.19%
408 $29,000
Q1 2020

Apr 29, 2020
BUY
$44.49 - $93.39 $27,583 - $57,901
620 New
620 $27,000
Q4 2019

Feb 05, 2020
SELL
$66.49 - $137.73 $23,537 - $48,756
-354 Closed
0 $0
Q3 2019

Oct 15, 2019
BUY
$31.0 - $89.73 $10,974 - $31,764
354 New
354 $27,000

Others Institutions Holding ALLK

# of Institutions
79
Shares Held
68.8M
Call Options Held
20.9K
Put Options Held
0
View Full List

About Allakos Inc.

ALLK Quotes by TradingView
  • Ticker ALLK
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 84,726,096
  • Market Cap $24.6M
  • Description
  • Allakos Inc., a clinical stage biopharmaceutical company, develops therapeutics that target immunomodulatory receptors present on immune effector cells in allergy, inflammatory, and proliferative diseases. The company's lead monoclonal antibody is lirentelimab (AK002), which is in a Phase III study for the treatment of eosinophilic gastritis and...
More about ALLK
Track This Portfolio

Track Simplex Trading, LLC Portfolio

Follow Simplex Trading, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Simplex Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Simplex Trading, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email